Abstract
BackgroundSystemic immune dysregulation associated with chronic autoimmune diseases such as systemic lupus erythematosus (SLE) as well as immunomodulatory medications used for their treatment have been associated with an increased risk...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
